New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune‐checkpoint inhibitors-Reference-Cited by-同舟云学术

New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune‐checkpoint inhibitors

Published:2022-06-10 Issue:1 Volume:19 Page:179-186
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Ab Rahman Ahmad Sufian¹²^ORCID,Strother Robert Matthew¹³^ORCID,Paddison Johanna¹⁴

Affiliation:

1. Christchurch Medical Oncology Department Christchurch New Zealand

2. Cancer CRI Centre Kuala Lumpur Malaysia

3. Department of Medicine University of Otago Christchurch New Zealand

4. Timaru Hospital South Canterbury District Health Board Timaru New Zealand

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13801

Reference29 articles.

1. Cancer: Historical Summary 1948–2015.Ministry of Health. Accessed October 21 2021.https://www.health.govt.nz/publication/cancer‐historical‐summary‐1948‐2015

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

4. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review;International Journal of Molecular Sciences;2023-08-03

2. ARCHITECTURAL SOLUTION FOR THE DISTRIBUTION OF SOFTWARE AND HARDWARE SYSTEMS FOR MONITORING POTENTIALLY UNSAFE OBJECTS;International Journal of GEOMATE;2023-07-31

3. A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments;Cancers;2022-08-04